4//SEC Filing
O'Keefe Kenneth W 4
Accession 0001765581-23-000096
CIK 0001232524other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:49 PM ET
Size
7.8 KB
Accession
0001765581-23-000096
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Award
Ordinary Shares
2023-08-11+3,075→ 25,964 total - Sale
Ordinary Shares
2023-08-14$138.16/sh−1,241$171,455→ 24,723 total
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (4)
- [F1]Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001397661
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:49 PM ET
- Size
- 7.8 KB